ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,629.00
0.55%
S&P ASX All Technology
3,016.30
1.48%
Brent Oil
82.765
0.00%
US Dollar vs AUD
1.514
0.00%
Bitcoin
63,335.06
-0.87%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Bioventus Inc (BVS)

  7. Bioventus Inc (BVS) News

BVS Bioventus Inc

3.97
0.01 (0.25%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Bioventus Inc BVS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.01 0.25% 3.97 10:00:00
Open Price Low Price High Price Close Price Previous Close
4.04 3.94 4.1199 3.97 3.96
more quote information »

Recent News

Date Time Source Heading
29/4/202421:30GLOBEBioventus to Report First Quarter of Fiscal Year 2024..
12/3/202422:30GLOBEBioventus Announces Fourth Quarter and Full Year 2023..
05/3/202400:00GLOBEBioventus to Report Fourth Quarter of Fiscal Year 2023..
07/2/202408:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23/1/202408:07EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
20/1/202400:27EDGAR2Form 8-K - Current report
19/1/202408:15GLOBEBioventus Enters into an Amendment with its Credit Agreement..
13/1/202409:10EDGAR2Form 8-K - Current report
13/1/202408:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/1/202408:39EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/1/202408:15GLOBEBioventus Announces Inducement Equity to President and Chief..
10/1/202400:55EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/12/202300:00EDGAR2Form 8-K - Current report
20/12/202308:30GLOBEBioventus Names Robert Claypoole as President and Chief..
07/12/202300:00GLOBEBioventus Agrees to Nationwide Contract with Aetna™ Medicare..
07/11/202323:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202323:35EDGAR2Form 8-K - Current report
07/11/202323:00GLOBEBioventus Reports Third Quarter Financial Results; Raises..
31/10/202322:00GLOBEBioventus to Report Third Quarter of Fiscal Year 2023..
20/9/202311:52GLOBEBioventus to Present at the Cantor Global Healthcare..
07/9/202306:30GLOBEBioventus to Present at the Morgan Stanley 21st Annual..
08/8/202322:42EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202322:02EDGAR2Form 8-K - Current report
08/8/202321:30GLOBEBioventus Reports Second Quarter Financial Results;..
04/8/202322:30GLOBEBioventus to Present at the Canaccord Genuity 43rd Annual..
02/8/202307:35GLOBEBioventus to Report Second Quarter of Fiscal Year 2023..
23/5/202321:30GLOBEBioventus Completes Divestiture of its Wound Business
17/5/202306:15GLOBEBioventus Reports First Quarter Financial Results
16/5/202307:33GLOBEBioventus Reschedules Reporting of First Quarter Fiscal Year..
11/5/202321:00GLOBEBioventus Reschedules Earnings Call to May 16, 2023; Files..
10/5/202323:00GLOBEBioventus Announces Divestiture of its Wound Business

Your Recent History

NASDAQ
BVS
Bioventus
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved